
1. plos pathog. 2011 apr;7(4):e1002017. doi: 10.1371/journal.ppat.1002017. epub 2011
apr 21.

engineered resistance plasmodium falciparum development transgenic
anopheles stephensi.

isaacs at(1), li f, jasinskiene n, chen x, nirmala x, marinotti o, vinetz jm,
james aa.

author information: 
(1)department microbiology molecular genetics, school medicine,
university california, irvine, california, united states america.

transposon-mediated transformation used produce anopheles stephensi that
express single-chain antibodies (scfvs) designed target human malaria
parasite, plasmodium falciparum. scfvs, m1c3, m4b7, m2a10, derived
from mouse monoclonal antibodies inhibit either ookinete invasion the
midgut sporozoite invasion salivary glands. scfvs target the
parasite surface, m4b7 m2a10, fused anopheles gambiae
antimicrobial peptide, cecropin a. previously-characterized anopheles cis-acting 
dna regulatory elements included transgenes coordinate scfv
production parasite development. gene amplification immunoblot analyses 
showed promoter-specific increases transgene expression blood-fed females. 
transgenic mosquito lines expressing scfv genes significantly
lower infection levels controls challenged p. falciparum.

doi: 10.1371/journal.ppat.1002017 
pmcid: pmc3080844
pmid: 21533066  [indexed medline]

